Noxsano Inc

Noxsano is a wound care company that develops medical treatments for human and veterinary applications by delivering nitric oxide to the wound bed. Their primary technology platform, marketed as Restore, utilizes pads and hydrogels that are activated with water or saline to generate nitric oxide at the point of use. This technology is designed to speed healing, prevent infection, and restore normal healing processes in both acute and chronic wounds, including surgical incisions and complex injuries. By delivering potent nitric oxide therapy locally, the products offer a convenient and cost-effective alternative to traditional wound management techniques.

The company’s approach is particularly valuable for veterinary professionals treating difficult wounds where traditional surgical intervention may be challenging, costly, or not an option. Clinical testimonials and case studies demonstrate the utility of Restore products in managing severe injuries, including de-gloved paws, burns, and chronic wounds that have failed to heal with conventional treatments. By providing a non-toxic, easy-to-apply solution, Noxsano helps clinicians minimize bandaging and improve patient outcomes in outpatient and clinical settings, addressing a significant need in veterinary wound care.